Amikacin liposome and Moxetumomab Pasudotox-tdfk
Determining the interaction of Amikacin liposome and Moxetumomab Pasudotox-tdfk and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: amikacin liposome
Brand name: Arikayce
Synonyms: Amikacin (Oral Inhalation)
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Amikacin liposome-Moxetumomab pasudotox-tdfk Intravenous
- Amikacin liposome-Moxifloxacin
- Amikacin liposome-Moxifloxacin (Systemic)
- Amikacin liposome-Moxifloxacin Hydrochloride
- Amikacin liposome-Moxifloxacin Injection
- Amikacin liposome-Moxifloxacin Intravenous
- Moxetumomab Pasudotox-tdfk-Amikacin liposome Inhalation
- Moxetumomab Pasudotox-tdfk-Amikacin Sulfate
- Moxetumomab Pasudotox-tdfk-Amikin
- Moxetumomab Pasudotox-tdfk-Amikin Pediatric
- Moxetumomab Pasudotox-tdfk-Amiloride
- Moxetumomab Pasudotox-tdfk-Amiloride and Hydrochlorothiazide